Department of Ophthalmology, University of Toronto, Toronto, Ontario, Canada.
Cornea. 2010 Aug;29(8):878-82. doi: 10.1097/ICO.0b013e3181cb40f6.
To examine the effect of successful repositioning/rebubbling of the graft on endothelial cell counts (ECCs) in eyes after Descemet stripping automated endothelial keratoplasty.
This retrospective study reviewed the outcomes of 58 eyes that underwent Descemet stripping automated endothelial keratoplasty. Fifty-one eyes were attached after surgery. Seven were detached and underwent rebubbling with minimal manipulation in 5 and significant manipulation in 2, after which the graft was attached and clear. Visual outcomes and endothelial cell loss at 6 months were compared between eyes that underwent repositioning/rebubbling and those that did not. The following were excluded: 2 eyes that had primary failure, 2 eyes that had rejection, 1 eye that failed to attach after rebubbling, 2 eyes that failed to clear after rebubbling, and 24 eyes that did not have ECC at 6 months.
The 2 groups were comparable considering age, preoperative best-corrected visual acuity, surgical variables, combined procedures, donor cell count, and graft size. The mean postoperative spherical equivalent, manifest and topographic astigmatism, uncorrected visual acuity, and best-corrected visual acuity did not differ significantly between the 2 groups at 6 months. Mean pre- and postoperative ECC did not differ significantly between the group that underwent repositioning/rebubbling and the group that did not (preoperative counts 2742 +/- 268 vs. 2747 +/- 353 and postoperative counts 1590 +/- 367 vs. 1746 +/- 491, respectively). Endothelial cell loss also did not differ significantly between the 2 groups, although there was a trend to greater cell loss in the reattachment group (-39.4% +/- 11.1% vs. -38.3% +/- 16.2%, respectively; P = 0.6).
Successful reattachment procedure does not seem to cause significant endothelial cell loss.
研究撕囊自动化角膜内皮移植术后成功复位/再注气对角膜内皮细胞计数(ECC)的影响。
本回顾性研究分析了 58 例接受撕囊自动化角膜内皮移植术的患者的结局。术后 51 例眼贴附,7 例眼脱离,5 例经最小化操作行再注气后贴附,2 例经显著化操作后贴附,之后均恢复透明。比较行复位/再注气与未行复位/再注气的眼的视力结果和 6 个月时的内皮细胞丢失。排除标准:2 例原发性失败,2 例排斥反应,1 例再注气后未贴附,2 例再注气后未恢复透明,24 例 6 个月时无 ECC。
2 组患者的年龄、术前最佳矫正视力、手术变量、联合手术、供体细胞计数和移植物大小相似。2 组患者术后 6 个月时的平均术后球镜等效、显性和地形散光、未矫正视力和最佳矫正视力无显著差异。行复位/再注气组与未行复位/再注气组的术前和术后 ECC 差异无统计学意义(术前计数分别为 2742 +/- 268 与 2747 +/- 353,术后计数分别为 1590 +/- 367 与 1746 +/- 491)。2 组患者的内皮细胞丢失也无显著差异,尽管再贴附组的细胞丢失趋势更大(-39.4% +/- 11.1%与-38.3% +/- 16.2%;P = 0.6)。
成功的再贴附术似乎不会导致明显的内皮细胞丢失。